Copyright
©2014 Baishideng Publishing Group Inc.
World J Hepatol. Jun 27, 2014; 6(6): 370-383
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.370
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.370
Figure 1 Suggested algorithm for preemptive therapy.
Figure adapted from Ref. [62].
Figure 2 Time to the onset of cytomegalovirus disease in solid organ transplant recipients who received three mo of oral ganciclovir or valganciclovir prophylaxis.
Data obtained from the study by Paya et al[5].
- Citation: Bruminhent J, Razonable RR. Management of cytomegalovirus infection and disease in liver transplant recipients. World J Hepatol 2014; 6(6): 370-383
- URL: https://www.wjgnet.com/1948-5182/full/v6/i6/370.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i6.370